Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $146.12M.
ENTERPRISE VALUE (EV)
$146.12M
Cue Biopharma, Inc.
Market Cap
$173.26M
Enterprise Value (EV)
$146.12M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cue Biopharma, Inc. (CUE) | $173.26M | $146.12M |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.23M | $54.57M |
| Nkarta, Inc. (NKTX)vs › | $173.50M | $222.08M |
| Precision BioSciences, Inc. (DTIL)vs › | $173.75M | $115.78M |
| Compass Therapeutics, Inc. (CMPX)vs › | $175.39M | $149.57M |
| MediWound Ltd. (MDWD)vs › | $170.85M | $176.04M |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.85M | $190.70M |
| Journey Medical Corporation (DERM)vs › | $178.96M | $178.86M |
| OptimizeRx Corp. (OPRX)vs › | $165.88M | $161.27M |
| Quanterix Corporation (QTRX)vs › | $164.64M | $153.85M |
Market Cap
$173.26M
Total Debt
$0.00
Cash
$27.14M
Enterprise Value
$146.12M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
